Dena Marrinucci

Dr. Marrinucci is a life science entrepreneur with a passion for introducing diagnostic technologies with potential to transform human health. She co-founded Truvian in late 2015 and leads research, operations, program management and strategic partnerships for the company. Prior to founding Truvian, Dr. Marrinucci founded Epic Sciences in 2008 and was the company’s Chief Scientific Officer. During her tenure at Epic, Dr. Marrinucci developed a novel circulating tumor cell technology and helped grow the company, overseeing its diagnostic collaborations with pharmaceutical companies and developing its clinical laboratory and assay development operations.

Dr. Marrinucci has been named to MIT Technology Review’s 35 Innovators Under 35, Foreign Policy’s Top 100 Leading Global Thinkers, PharmaVoice 100’s Top Entrepreneurs, The Daily Transcript’s 40 Under 40 Business Professionals, San Diego Business Journal’s Most Influential Women in Technology, and Stella Labs’ Entrepreneur of the Year. She was also named a 2016 Life Science Catalyst Award winner, has authored dozens of peer reviewed publications and is an inventor on 12 patents. Dr. Marrinucci also serves as an Advisor for Lynx Biosciences, a cancer diagnostic company. She holds a B.S. in Chemistry from the University of Vermont and a Ph.D. in Chemical Biology from The Scripps Research Institute.